Redcare Pharmacy falls on 2025 sales miss, hit by soft non-prescription growth

Redcare Pharmacy NV

07/01/2026 08:48

** Shares of Redcare Pharmacy RDC.DE fall 8.9% after the German online drug retailer reported 2025 sales below market expectations

** The company reached annual sales of 2.9 billion euros ($3.4 billion), which was 1% below consensus according to Baader Helvea

** "Group’s main miss is related to non-Rx (non-prescription) sales growth, which reached +15%, while the guidance was >+18%," Baader analysts write

** Redcare Pharmacy's stock falls to the bottom of Germany's mid-cap index .MDAXI

($1 = 0.8564 euros)

(Reporting by Tristan Veyet)

((Tristan.chabba@thomsonreuters.com))